Safe Implant Technology ApS: Financial statements 2022
CVR: 38969153
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,485 and a net result of DKK -6,817 compared with DKK -6,966 the year before. Equity in the 2022 report amounted to DKK 26,842. The solvency ratio was 2.9%.
- Gross Profit
- DKK -6,485
- Profit/Loss
- DKK -6,817
- Equity
- DKK 26,842
- Total Assets
- DKK 923,828
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6 t. | -7 t. | 27 t. | 0 |
| 2021 | - | -7 t. | -7 t. | 34 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 44 t. | 0 |
Official annual report
Keep an eye on Safe Implant Technology ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Safe Implant Technology ApS has published its annual report for 2021. Gross profit came to DKK -6,796, and the net result was DKK -6,966.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.